» Articles » PMID: 23409120

IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFNγ

Overview
Journal PLoS One
Date 2013 Feb 15
PMID 23409120
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

IL-34 is a recently identified cytokine that signals via the M-CSF receptor and promotes monocyte survival. Depending on the environment, monocytes can differentiate into macrophages (Mφ) or dendritic cells (DC). A wide spectrum of Mφ and DC subsets, with distinct phenotypes and functions, has been described. To date, the phenotype of monocytes exposed to IL-34 remains unexplored. We report here that IL-34 induces the differentiation of monocytes into CD14(high) CD163(high) CD1a(-) Mφ (IL-34-Mφ). Upon LPS stimulation, IL-34-Mφ exhibit an IL-10(high) IL-12(low) M2 profile and express low levels of the costimulatory molecules CD80 and CD86. IL-34-Mφ exhibit poor T cell costimulatory properties, and have potent immunosuppressive properties (decrease of TCR-stimulated T cell proliferation). For all the parameters analyzed, IL-34-Mφ are phenotypically and functionally similar to M-CSF-Mφ. IL-34 appears as efficient as M-CSF in inducing the generation of immunosuppressive Mφ. Moreover, the generation of IL-34-Mφ is mediated through the M-CSF receptor, is independent of endogenous M-CSF consumption and is potentiated by IL-6. In an attempt to identify strategies to prevent a deleterious M2 cell accumulation in some pathological situations, we observed that IFNγ and GM-CSF prevent the generation of immunosuppressive Mφ induced by IL-34. IFNγ also switches established IL-34-Mφ into immunostimulatory Mφ. In conclusion, we demonstrate that IL-34 drives the differentiation of monocytes into immunosuppressive M2, in a manner similar to M-CSF, and that IFNγ and GM-CSF prevent this effect.

Citing Articles

Interleukin-34 and debris clearance by mononuclear phagocytes drive retinal pigment epithelium regeneration in zebrafish.

Leach L, Gonzalez R, Jayawardena S, Gross J bioRxiv. 2025; .

PMID: 39868193 PMC: 11761032. DOI: 10.1101/2025.01.10.632236.


Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition.

Beielstein A, Izquierdo E, Blakemore S, Nickel N, Michalik M, Chawan S Cell Rep Med. 2024; 5(12):101830.

PMID: 39603243 PMC: 11722127. DOI: 10.1016/j.xcrm.2024.101830.


AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization.

Liu Z, Hu S, Zhao X, Xu W, Ju F, Gu M J Immunother Cancer. 2024; 12(10).

PMID: 39448199 PMC: 11499773. DOI: 10.1136/jitc-2024-009877.


A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma.

Tang X, Shimada H, Ikegaki N Curr Oncol. 2024; 31(6):3212-3226.

PMID: 38920727 PMC: 11202629. DOI: 10.3390/curroncol31060243.


Innate immune cellular therapeutics in transplantation.

Ott L, Cuenca A Front Transplant. 2023; 2.

PMID: 37994308 PMC: 10664839. DOI: 10.3389/frtra.2023.1067512.


References
1.
Gliniak B, Park L, Rohrschneider L . A GM-colony-stimulating factor (CSF) activated ribonuclease system transregulates M-CSF receptor expression in the murine FDC-P1/MAC myeloid cell line. Mol Biol Cell. 1992; 3(5):535-44. PMC: 275606. DOI: 10.1091/mbc.3.5.535. View

2.
Fraticelli P, Sironi M, Bianchi G, DAmbrosio D, Albanesi C, Stoppacciaro A . Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest. 2001; 107(9):1173-81. PMC: 209276. DOI: 10.1172/JCI11517. View

3.
Sica A, Schioppa T, Mantovani A, Allavena P . Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006; 42(6):717-27. DOI: 10.1016/j.ejca.2006.01.003. View

4.
MHoma Soudja S, Ruiz A, Marie J, Lauvau G . Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity. 2012; 37(3):549-62. PMC: 3456987. DOI: 10.1016/j.immuni.2012.05.029. View

5.
Chihara T, Suzu S, Hassan R, Chutiwitoonchai N, Hiyoshi M, Motoyoshi K . IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 2010; 17(12):1917-27. DOI: 10.1038/cdd.2010.60. View